Bruton’s Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials

In the last few decades, there has been a growing interest in Bruton’s tyrosine kinase (BTK) and the compounds that target it. BTK is a downstream mediator of the B-cell receptor (BCR) signaling pathway and affects B-cell proliferation and differentiation. Evidence demonstrating the expression of BT...

Descrición completa

Detalles Bibliográficos

Principais autores:	Dariusz Rozkiewicz, Justyna Magdalena Hermanowicz, Iwona Kwiatkowska, Anna Krupa, Dariusz Pawlak
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2023-03-01
Series:	Molecules
Assuntos:	Bruton’s tyrosine kinase inhibitors Bruton’s tyrosine kinase cancer solid tumor autoimmune disease
Acceso en liña:	https://www.mdpi.com/1420-3049/28/5/2400
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!